Back to search

National and Kapodistrian University of Athens

Τοπική θεραπεία πειραματικής οστεομυελίτιδος από χρυσίζοντα σταφυλόκοκκο ανθεκτικό στη μεθικιλλίνη (MRSA) σε κονίκλους, με τεϊκοπλανίνη ενσωματωμένη σε πολυμερές γαλακτικού οξέος

Abstract

dc:description

Chronic osteomyelitis is difficult to treat, due to the characteristics of the bone tissue and the tissue necrosis that occurs. Recently the necessity of local antibiotic therapy has been recognized. In this experimental study we present our results in treating an induced experimental osteomyelitis (modified Norden model) caused by Staphylococcus aureus methicillin resistant in rabbits, with the local use of a racemic mixture of lactic acid polymer and teicoplanin (Biodegradable Drug Delivery System). The molecular weight of the polymer was 20.000 and the total weight of the mixture polymer-teicoplanin was 500 mg. Teicoplanin was mixed at a ratio of 1:10. The bone infection was achieved with the induction of 2x10⁷ cfu/ml of the above microorganism. In vitro the Staphylococcus aureus we used was susceptible to teicoplanin with MIC: 0,25 and MBC: 0,50. 77 rabbits were used in our study, which were divided in two groups. The first group (n=35) was used as a control group for monitoring the outcome of the bone infection for 13 weeks after the induction of the bone infection. The second (treatment) group (n=45), was used to monitor the treatment outcome of the bone infection and evaluate the pharmacokinetics of the mixture of polymer-teicoplanin for 10 weeks after initiation of treatment. In both groups the osteomyelitis was established 3 weeks after the induction of the Staphylococcus aureus. In the control group chronic osteomyelitis was established 6 weeks after induction and there was no significant change of the implanted inoculum even 10 weeks after induction despite the surgical debridement 3 weeks after the induction of the infection. In the treatment group the bone cultures were negative for the strain of the Staphylococcus aureus we used 6 weeks after initiation of treatment and bacterial killing levels were achieved locally for more than 9 weeks. The systemic levels of teicoplanin throughout the experiment were zero. The advantages of our biodegradable system teicoplanin-lactic acid polymer are, the very high levels of antibiotic locally with minimal detection of antibiotic systemically, the avoidance of second surgical procedure to remove the Drug Delivery System, the lack of significant tissue reactions to our biodegradable system and the avoidance of daily administration of antibiotics for a prolonged period of time.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2002

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Σαρρής, Ιωάννης
  • Sarris, Ioannis

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/21553

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Σαρρής, Ιωάννης; Sarris, Ioannis. Τοπική θεραπεία πειραματικής οστεομυελίτιδος από χρυσίζοντα σταφυλόκοκκο ανθεκτικό στη μεθικιλλίνη (MRSA) σε κονίκλους, με τεϊκοπλανίνη ενσωματωμένη σε πολυμερές γαλακτικού οξέος. National and Kapodistrian University of Athens, 2002. http://hdl.handle.net/10442/hedi/21553